Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131759) titled 'A clinical study evaluating the efficacy and safety of Gecacitinib Hydrochloride based combination regimen in the treatment of hemophagocytic syndrome' on Sept. 6.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital
Condition:
Hemophagocytic lymphohistiocytosis
HLH
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-21
Target Sample Size: Experimental group:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=339013
Published by HT Digital Content Ser...